Nuveen Asset Management, LLC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is 2.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2022$476,000
-79.3%
255,493
-41.9%
0.00%
-100.0%
Q4 2021$2,295,000
-12.1%
439,653
-1.8%
0.00%0.0%
Q3 2021$2,611,000
-35.8%
447,800
-11.3%
0.00%0.0%
Q2 2021$4,067,000
+8.3%
504,599
+11.7%
0.00%0.0%
Q1 2021$3,757,000
+11.7%
451,551
+1.8%
0.00%0.0%
Q4 2020$3,363,000
-26.8%
443,654
+2.9%
0.00%
-50.0%
Q3 2020$4,594,000
+48.9%
430,948
+111.7%
0.00%
+100.0%
Q2 2020$3,085,000
+29.8%
203,529
-28.7%
0.00%0.0%
Q1 2020$2,377,000
-51.4%
285,416
-1.4%
0.00%
-50.0%
Q4 2019$4,894,000
-23.3%
289,530
-15.8%
0.00%
-33.3%
Q3 2019$6,383,000
-37.8%
343,731
-23.3%
0.00%
-25.0%
Q2 2019$10,257,000
+22.9%
448,289
+12.9%
0.00%
-91.1%
Q1 2019$8,345,000
+62.3%
396,985
-11.2%
0.04%
+40.6%
Q4 2018$5,142,000
-57.3%
447,098
-14.7%
0.03%
-50.0%
Q3 2018$12,029,000
-2.5%
524,135
-5.3%
0.06%
-17.9%
Q2 2018$12,343,000
+6.2%
553,476
+8.8%
0.08%
+2.6%
Q1 2018$11,619,000
-32.2%
508,489
-22.3%
0.08%
-30.9%
Q4 2017$17,139,000
+4.7%
654,150
-10.3%
0.11%
+2.8%
Q3 2017$16,377,000
-11.0%
729,498
+8.4%
0.11%
-9.3%
Q2 2017$18,399,000
+3.2%
672,722
-8.7%
0.12%
+11.3%
Q1 2017$17,835,000
+18.2%
736,997
+1.3%
0.11%
+37.7%
Q4 2016$15,094,000
-21.0%
727,429
+3.8%
0.08%
-31.2%
Q3 2016$19,107,000
+86.9%
700,923
-1.4%
0.11%
+77.8%
Q2 2016$10,225,000
+14.7%
710,571
+14.5%
0.06%
+34.0%
Q1 2016$8,917,000
-23.9%
620,541
+13.8%
0.05%
-21.7%
Q4 2015$11,719,000
+185.2%
545,321
+114.7%
0.06%
+160.9%
Q3 2015$4,109,000253,9510.02%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders